Novel liposome composition for the treatment of interstitial lung diseases
December 1, 2009. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesCompositions containing aqueous dispersions of lipid spheres Drug delivery method and inhalation device therefor Small particle aerosol generator for treatment of respiratory disease including the lungs Aerosol inhalation apparatus Pharmaceutical compositions Compositions comprising aqueous dispersions of lipid spheres Novel liposome composition for sustained release of steroidal drugs in lungs Patent #: 4906476 InventorAssigneeApplicationNo. 444738 filed on 12/01/1989US Classes:424/450, Liposomes264/4.1, Liquid encapsulation utilizing an emulsion or dispersion to form a solid-walled microcapsule (includes liposome)424/434Mucosal (e.g., nasal, etc.)ExaminersPrimary: Page, Thurman K.Assistant: Kishore, G. S. Attorney, Agent or FirmForeign Patent References
International ClassesA61K 037/22A61F 013/00 B01J 013/02 AbstractA non-conventional lipid particle formulation for the sustained release and delivery of steroids into deep lung is disclosed. The formulation provides prolonged release of the drug, improved therapeutic ratio, lower toxicity, reduced systemic side effects, and stability for several months. The formulation is in particular suitable for treatment of interstitial lung diseases.Other References
Field of SearchLiposomesGelatin Mucosal (e.g., nasal, etc.) MEANS FOR PASSING RESPIRATORY GAS THROUGH BODY OF LIQUID BEFORE INHALATION Artificial gill, or means for separating entrained air from liquid stream Liquid encapsulation utilizing an emulsion or dispersion to form a solid-walled microcapsule (includes liposome) | |
